(0)
SEOUL, South Korea, May 28, 2021 /PRNewswire/ Dr. Seungpil Yu is a living witness to the long history of Yuyu Pharma, which celebrated its 80
th anniversary this year, having laid the foundation for Yuyu Pharma to continue to thrive well into its 100
th year. While in the United States, Dr. Yu received his PhD in International Business Administration from Columbia University and was an assistant professor at Pace University s graduate school before returning home to Korea to take over the family business.
During his 46-year term running Yuyu Pharma, Dr. Yu transformed Yuyu s product portfolio from one focusing on generic drugs to one focusing on specialty drugs. In anticipation of an aging society, Dr. Yu oversaw the introduction of two new improved drugs: Maxmarvil, for the treatment of osteoporosis and Yuclid, an antiplatelet drug. During his tenure, Yuyu Pharma, while small, had grown into a shiny diamond-like company.
Yuyu Pharma Publishes History for 80th Anniversary
USA - English
News provided by
Share this article
Share this article
SEOUL, South Korea, March 3, 2021 /PRNewswire/ Yuyu Pharma (KRX: 000220, CEO Robert Wonsang Yu), in anticipation of the 80th anniversary of its establishment on February 28th, 2021, published its history of challenges and changes over the past 80 years. The history is told in storytelling format centered around a series of interviews with the people who have shared this history.
Yuyu Pharma Publishes History for 80th Anniversary
The 80th anniversary history was organized based on visual data giving a glimpse of that time period, such as Yuyu s product advertisements during the 1940 s and 50 s, product instruction manuals from the 1960 s, and interviews with former and current employees.
Yuyu Pharma Publishes History for 80th Anniversary iltempo.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iltempo.it Daily Mail and Mail on Sunday newspapers.